Alert detail

FDA Approval: ALECENSA (ALECTINIB HYDROCHLORIDE) — Type 1 - New Molecular Entity

Policy ID: FDA-NDA208434Specialty: OncologyAdded: 6/17/2026Effective: 2015-12-11federal register
Routine

Full alert analysis requires a subscription

Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.